TY  - GEN
AU  - Yap,Yoon-Sim
AU  - Kwok,Li-Lian
AU  - Syn,Nicholas
AU  - Chay,Wen Yee
AU  - Chia,John Whay Kuang
AU  - Tham,Chee Kian
AU  - Wong,Nan Soon
AU  - Lo,Soo Kien
AU  - Dent,Rebecca Alexandra
AU  - Tan,Sili
AU  - Mok,Zuan Yu
AU  - Koh,King Xin
AU  - Toh,Han Chong
AU  - Koo,Wen Hsin
AU  - Loh,Marie
AU  - Ng,Raymond Chee Hui
AU  - Choo,Su Pin
AU  - Soong,Richie Chuan Teck
TI  - Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial
SN  - 2374-2445
PY  - 2017///1128
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - adverse effects
KW  - Asian People
KW  - genetics
KW  - Capecitabine
KW  - Chi-Square Distribution
KW  - Dihydrouracil Dehydrogenase (NADP)
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Folic Acid
KW  - blood
KW  - Genetic Predisposition to Disease
KW  - Genome-Wide Association Study
KW  - Hand-Foot Syndrome
KW  - Humans
KW  - Incidence
KW  - Intracellular Signaling Peptides and Proteins
KW  - Kaplan-Meier Estimate
KW  - Logistic Models
KW  - Male
KW  - Membrane Proteins
KW  - Microfilament Proteins
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasms
KW  - Odds Ratio
KW  - Pharmacogenomic Variants
KW  - Polymorphism, Single Nucleotide
KW  - Predictive Value of Tests
KW  - Pyridoxine
KW  - administration & dosage
KW  - Risk Assessment
KW  - Risk Factors
KW  - Severity of Illness Index
KW  - Singapore
KW  - epidemiology
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1001/jamaoncol.2017.1269
ER  -